LianBio Information, Including Revenue, Investors, Funding, Competitors & Key Metrics

LianBio’s mission is to catalyze the development and accelerate availability of paradigm-shifting medicines to patients in China and major Asian markets through partnerships that provide access to the best science-driven therapeutic discoveries. LianBio collaborates with world-class partners across a diverse array of therapeutic and geographic areas to build out a pipeline based on disease relevance and the ability to impact patients with transformative mechanisms and precision-based therapeutic

Company Highlights
Year Founded

2019

icon-altEmployees

72

Location (HQ)

CHN

Since Last Funding

4 years 1 month

Monthly Website Visitors

1.7K

icon-altTotal Investment Amt

$300M

Last Funding Round

Series A

icon-altMoM Headcount Growth

-1.37%

icon-altYoY Headcount Growth

-36.81%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Pharmaceutical

Biopharma